Same Indication

Lisinopril vs Upadacitinib

Lisinopril vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Lisinopril and Upadacitinib.

Mechanism of Action

Lisinopril: ACE inhibitor preventing conversion of angiotensin I to angiotensin II.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Lisinopril — 12 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Lisinopril — C21H31N3O5; Upadacitinib — C17H19F3N6O.

Molecular Weight: Lisinopril — 405.4900 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Lisinopril — Small molecule; Upadacitinib — Small molecule.